Mirati Therapeutics, Inc.

Russell Investments Group, Ltd.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/5/2024

Shares

266

Value ($000)

16

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/5/2024	16	0.0%	266	12/31/2023
2023 Q3	11/13/2023	244	0.0%	5,595	9/30/2023
2023 Q2	8/10/2023	2,117	0.0%	58,597	6/30/2023
2023 Q1	5/9/2023	2,390	0.0%	64,274	3/31/2023
2022 Q4	2/8/2023	2,720	0.0%	60,026	12/31/2022
2022 Q3	11/4/2022	1,873	0.0%	26,840	9/30/2022
2022 Q2	7/29/2022	1,618	0.0%	24,139	6/30/2022
2022 Q1	5/5/2022	4,789	0.0%	58,254	3/31/2022
2021 Q4	1/21/2022	7,099	0.0%	48,406	12/31/2021
2021 Q3	11/8/2021	6,849	0.0%	38,726	9/30/2021
2021 Q2	8/4/2021	5,416	0.0%	33,536	6/30/2021
2021 Q1	5/10/2021	2,217	0.0%	12,947	3/31/2021
2020 Q4	2/8/2021	8,971	0.0%	40,860	12/31/2020
2020 Q3	11/9/2020	5,829	0.0%	35,114	9/30/2020
2020 Q2	8/5/2020	2,371	0.0%	20,776	6/30/2020
2020 Q1	5/6/2020	1,905	0.0%	24,758	3/31/2020
2019 Q4	1/29/2020	3,771	0.0%	29,282	12/31/2019